Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · October 20, 2022

Association Between SGLT2 Inhibitor Use and a Reduced Risk for New-Onset Type 2 Diabetes in Adults With Prediabetes

The Journal of Clinical Endocrinology and Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

The Journal of Clinical Endocrinology and Metabolism
Sodium-Glucose Cotransporter 2 Inhibitors and New-onset Type 2 Diabetes in Adults with Prediabetes: systematic review and meta-analysis of randomized controlled trials
J. Clin. Endocrinol. Metab. 2022 Oct 11;[EPub Ahead of Print], Y Mori, OK Duru, KR Tuttle, S Fukuma, D Taura, N Harada, N Inagaki, K Inoue

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading